Evis Harja

Columbia University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

19h-index2.5kcitations40works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Advanced Glycation End Products research(24), NF-κB Signaling Pathways(6), Macrophage Migration Inhibitory Factor(6), Nuclear Receptors and Signaling(6), Diabetes, Cardiovascular Risks, and Lipoproteins(3)

Publications40 total

Supplementary Methods, Legends for Table 1, Figures 1-3 from Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling
2023Open Access
Supplementary Table 1 from Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling
2023Open Access
Supplementary Methods, Legends for Table 1, Figures 1-3 from Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling
2023Open Access
Data from Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling
2023Open Access
Data from Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling
2023Open Access
Supplementary Figure 1 from Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling
2023Open Access
Supplementary Figure 2 from Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling
2023Open Access
Supplementary Figure 2 from Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling
2023Open Access
Supplementary Figure 1 from Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling
2023Open Access
Supplementary Table 1 from Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling
2023Open Access
Supplementary Figure 3 from Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling
2023Open Access
Supplementary Figure 3 from Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling
2023Open Access
Regulation of Receptor for Advanced Glycation End Products (RAGE) Ectodomain Shedding and Its Role in Cell Function
Journal of Biological Chemistry·2016· 35 citedOpen Access
<sup>124</sup> I PET/CT in Patients with Differentiated Thyroid Cancer: Clinical and Quantitative Image Analysis
Thyroid·2016· 40 cited
AB0227 Extra Articuar Manifestations of Rheumatoid Arthritis - A Hospital Based Study in Albania
Annals of the Rheumatic Diseases·2014
Early And Long Term Outcomes Of Aortic Valve Surgery Combined Or Not With Cabg Surgery
International Journal of Clinical Therapeutics and Diagnosis·2014· 2 citedOpen Access
An Analysis of Characteristics of Subjects Examined for Incretin Effects on Pancreatic Pathology
Diabetes Technology & Therapeutics·2013· 31 cited
Abstract 541: RAGE Regulates Cellular Migration and Adhesion Through Proteolysis of Its Ectodomain
Arteriosclerosis Thrombosis and Vascular Biology·2013
Kalea Cancer Res 2010 suppl ALL
2012
Noninvasive monitoring the biology of atherosclerotic plaque development with radiolabeled annexin V and matrix metalloproteinase inhibitor in spontaneous atherosclerotic mice
Journal of Nuclear Cardiology·2010· 20 cited
page 1 of 2Next →

Frequent Co-authors

Ann Marie Schmidt(29), Barry I. Hudson(24), Anastasia Z. Kalea(17), Maria Arriero(17), Fiona See(14), Yan Lü(5), Yu Zou(4), Shi‐Fang Yan(4), Jong Sun Chang(3), Shi Fang Yan(3), Hojin Yang(3), Loredana Bucciarelli(3), Bernhard Moser(3), Michael Leitges(3), Marija Sedlar(3), Lynne L. Johnson(3), Rosa Rosario(2), Dmitri Belov(2), Evanthia Lalla(2), Ravichandran Ramasamy(2)